Disruption of Dihydronicotinamide Riboside:Quinone Oxidoreductase 2 (NQO2) Leads to Myeloid Hyperplasia of Bone Marrow and Decreased Sensitivity to Menadione Toxicity
Open Access
- 1 November 2002
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 277 (48), 46131-46139
- https://doi.org/10.1074/jbc.m208675200
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- In Vivo Role of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) in the Regulation of Intracellular Redox State and Accumulation of Abdominal Adipose TissueJournal of Biological Chemistry, 2001
- Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygenFree Radical Biology & Medicine, 2000
- Disruption of the DT Diaphorase (NQO1) Gene in Mice Leads to Increased Menadione ToxicityOnline Journal of Public Health Informatics, 1998
- Catalytic Properties of NAD(P)H:Quinone Oxidoreductase-2 (NQO2), a Dihydronicotinamide Riboside Dependent OxidoreductaseArchives of Biochemistry and Biophysics, 1997
- Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)Proceedings of the National Academy of Sciences of the United States of America, 1997
- Non-enzymatic and enzymatic activation of mitomycin C: Identification of a unique cytosolic activityInternational Journal of Cancer, 1996
- The experimental development of bioreductive drugs and their role in cancer therapyCancer and Metastasis Reviews, 1993
- DT-diaphorase and cancer chemotherapyBiochemical Pharmacology, 1992
- Molecular mechanisms of quinone cytotoxicityChemico-Biological Interactions, 1991
- Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6Biochemistry, 1990